store at low temperature
store at -80°C
Otilimab (GSK 3196165) is a humanized monoclonal antibody against granulocyt-macrophage colony-stimulating factor (GM-CSF). Otilimab has anti-inflammatory activity, regulates the biological function of GM-CSF by blocking the interaction between GM-CSF and its cell surface receptors, and can be used in studies to treat severe COVID-19 pneumonia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 122.00 | |
5 mg | In stock | $ 322.00 | |
10 mg | In stock | $ 549.00 | |
25 mg | In stock | $ 873.00 | |
50 mg | In stock | $ 1,170.00 | |
100 mg | In stock | $ 1,580.00 |
Description | Otilimab (GSK 3196165) is a humanized monoclonal antibody against granulocyt-macrophage colony-stimulating factor (GM-CSF). Otilimab has anti-inflammatory activity, regulates the biological function of GM-CSF by blocking the interaction between GM-CSF and its cell surface receptors, and can be used in studies to treat severe COVID-19 pneumonia. |
Synonyms | GSK 3196165, MOR103 |
Molecular Weight | N/A |
CAS No. | 1638332-55-4 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Otilimab 1638332-55-4 Tyrosine Kinase/Adaptors CSF-1R GSK 3196165 GSK3196165 MOR103 MOR 103 GSK-3196165 MOR-103 inhibitor inhibit